The ubiquitin-proteasome proteolytic pathway - PubMed (original) (raw)
Review
The ubiquitin-proteasome proteolytic pathway
A Ciechanover. Cell. 1994.
No abstract available
Similar articles
- The ubiquitin-proteasome pathway: on protein death and cell life.
Ciechanover A. Ciechanover A. EMBO J. 1998 Dec 15;17(24):7151-60. doi: 10.1093/emboj/17.24.7151. EMBO J. 1998. PMID: 9857172 Free PMC article. Review. No abstract available. - Compartment-specific functions of the ubiquitin-proteasome pathway.
Sommer T, Jarosch E, Lenk U. Sommer T, et al. Rev Physiol Biochem Pharmacol. 2001;142:97-160. doi: 10.1007/BFb0117492. Rev Physiol Biochem Pharmacol. 2001. PMID: 11190579 Review. No abstract available. - The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death.
Ciechanover A, Schwartz AL. Ciechanover A, et al. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2727-30. doi: 10.1073/pnas.95.6.2727. Proc Natl Acad Sci U S A. 1998. PMID: 9501156 Free PMC article. No abstract available. - On the spatial organization of ubiquitin-dependent proteolysis in HeLa cells.
Wójcik C. Wójcik C. Folia Histochem Cytobiol. 1997;35(2):117-8. Folia Histochem Cytobiol. 1997. PMID: 9151102 No abstract available. - Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.
Attaix D, Aurousseau E, Combaret L, Kee A, Larbaud D, Rallière C, Souweine B, Taillandier D, Tilignac T. Attaix D, et al. Reprod Nutr Dev. 1998 Mar-Apr;38(2):153-65. doi: 10.1051/rnd:19980202. Reprod Nutr Dev. 1998. PMID: 9638789 Review.
Cited by
- Evaluating Antimalarial Proteasome Inhibitors for Efficacy in Babesia Blood Stage Cultures.
Robbertse L, Fajtová P, Šnebergerová P, Jalovecká M, Levytska V, Barbosa da Silva E, Sharma V, Pachl P, Almaliti J, Al-Hindy M, Gerwick WH, Bouřa E, O'Donoghue AJ, Sojka D. Robbertse L, et al. ACS Omega. 2024 Oct 28;9(45):44989-44999. doi: 10.1021/acsomega.4c04564. eCollection 2024 Nov 12. ACS Omega. 2024. PMID: 39554424 Free PMC article. - Protein ubiquitination in ovarian cancer immunotherapy: The progress and therapeutic strategy.
Guo H, Wei J, Zhang Y, Wang L, Wan J, Wang W, Gao L, Li J, Sun T, Ma L. Guo H, et al. Genes Dis. 2023 Oct 29;11(6):101158. doi: 10.1016/j.gendis.2023.101158. eCollection 2024 Nov. Genes Dis. 2023. PMID: 39253578 Free PMC article. Review. - Targeting p97-Npl4 interaction inhibits tumor Treg cell development to enhance tumor immunity.
Nie P, Cao Z, Yu R, Dong C, Zhang W, Meng Y, Zhang H, Pan Y, Tong Z, Jiang X, Wang S, Zhu M, Han Y, Wang W, Zhang Y, Tan L, Li C, Xu Y, An L, Li B, Jiao S, Zhou Z. Nie P, et al. Nat Immunol. 2024 Sep;25(9):1623-1636. doi: 10.1038/s41590-024-01912-y. Epub 2024 Aug 6. Nat Immunol. 2024. PMID: 39107403 - Selected Functions and Disorders of Mitochondrial Metabolism under Lead Exposure.
Chlubek M, Baranowska-Bosiacka I. Chlubek M, et al. Cells. 2024 Jul 11;13(14):1182. doi: 10.3390/cells13141182. Cells. 2024. PMID: 39056765 Free PMC article. Review. - Key features of the innate immune response is mediated by the immunoproteasome in microglia.
Izadjoo S, Moritz KE, Khayrullina G, Bergman EM, Melvin BM, Stinson MW, Paulson SG, McCormack NM, Anderson KN, Lewis LA, Rotty JD, Burnett BG. Izadjoo S, et al. Res Sq [Preprint]. 2024 Jun 6:rs.3.rs-4467983. doi: 10.21203/rs.3.rs-4467983/v1. Res Sq. 2024. PMID: 38883799 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources